Phase III trial of fosbretabulin in combination with chemotherapy and radiotherapy as first-line treatment in patients with advanced non-small cell lung cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2011
At a glance
- Drugs Antineoplastics; Fosbretabulin
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 05 Mar 2008 New trial record.